INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,751 | -10.0% | 109,897 | +3.3% | 0.01% | -12.5% |
| Q2 2023 | $47,509 | -69.3% | 106,397 | +7.2% | 0.01% | -74.2% |
| Q4 2022 | $154,889 | +21.0% | 99,288 | +34.1% | 0.03% | +19.2% |
| Q3 2022 | $128,000 | 0.0% | 74,058 | -0.2% | 0.03% | +4.0% |
| Q2 2022 | $128,000 | -50.8% | 74,172 | +2.4% | 0.02% | -43.2% |
| Q1 2022 | $260,000 | -21.5% | 72,422 | +9.0% | 0.04% | -18.5% |
| Q4 2021 | $331,000 | -26.8% | 66,422 | +5.1% | 0.05% | -34.1% |
| Q3 2021 | $452,000 | -19.7% | 63,172 | +4.1% | 0.08% | -19.6% |
| Q2 2021 | $563,000 | +7.9% | 60,712 | +7.9% | 0.10% | 0.0% |
| Q1 2021 | $522,000 | +50.9% | 56,255 | +44.0% | 0.10% | +41.7% |
| Q4 2020 | $346,000 | -8.2% | 39,075 | +20.3% | 0.07% | -22.6% |
| Q3 2020 | $377,000 | – | 32,475 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |